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Dengue virus with four distinct serotypes belongs to Flavivirus, poses a signiﬁcant threat to human health
and becomes an emerging global problem. Membrane fusion is a central molecular event during viral
entry into host cell. To prevent viral infection it is necessary to interrupt the virus replication at an early
stage of attachment. Dengue Virus (DENV) envelope protein experiences conformational changes and it
causes the virus to fuse with host cell. Hinge region movement of domain I and II in envelope protein
facilitates the fusion process. Small molecules that bind in this pocket may have the ability to interrupt
the conformational changes that trigger fusion process. We chose different ﬂavonoids (baicalein, ﬁsetin,
hesperetin, naringenin/ naringin, quercetin and rutin) that possess anti dengue activity. Molecular
docking analysis was done to examine the inhibitory effect of ﬂavonoids against envelope protein of
DENV-2. Results manifest quercetin (ﬂavonoid found in Carica papaya, apple and even in lemon) as the
only ﬂavone that can interrupt the fusion process of virus by inhibiting the hinge region movement and
by blocking the conformational rearrangement in envelope protein. These novel ﬁndings using com-
putational approach are worthwhile and will be a bridge to check the efﬁcacy of compounds using
appropriate animal model under In vivo studies. This information can be used by new techniques and
provides a way to control dengue virus infection.
& 2016 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A major public health concern worldwide in recent years is a
most prevalent mosquito-borne viral pathogen dengue virus
(DENV). Presently around the world dengue is endemic in 112
countries [1,2]. Mostly in tropical and subtropical areas, each year
50–100 million individuals are infected with DENV resulting in
nearly 500,000 severe life-threatening illnesses and 25,000
deaths, [3,4]. Four distinct serotypes (DENV1-4) of dengue virus
are major contributors in circulation of virus in population. The
virus is transmitted to humans via the bite of the Aedes mosquito,
[5].
DENV belongs to the genus Flavivirus of family Flaviviridae
containing single-stranded RNA (positive-sense) genome [6]. A
polyprotein precursor is translated by ORF as NH2-C-prM-E-NS1-
NS2A-NS2B-NS3-NS4A-NS4B-NS5-COOH, [7,8]. In a mature virion,
C prM and E are structural proteins while other seven are non-
structural proteins, [9]. Viral nucleocapsid (RNA genomen open access article under the CC
ail.com (S. Rauf),encapsulated by multiple copies of C protein) is surrounded by a
host-cell-derived lipid bilayer (glycoprotein), comprises 180
anchored copies of M and E proteins arranged as 90 homodimers
at the surface of mature virion, [10–13]. E (envelope) protein
(54.5 kDa, 493–495 amino acid) is a major component of the virion
surface plays an important role in binding to the host receptor,
assists virus fusion (class II membrane fusion peptides), and
induces immunogenic response in host cell, [14]. Three domains
folded largely based on β sheets the N-terminus domain one (DI);
(central domain), domain two (DII) called as the fusion (or
dimerization) domain and domain three (DIII) immunoglobulin
(IgG) like domain are reported in E protein, [15].
At neutral pH, E protein of DENV exists as dimeric structure and
at the tip of Domain II between domain I and domain III the highly
conserved fusion peptide buried in a hydrophobic pocket thus
provides a shield from interaction with cellular membranes,
[16,17]. Within the acidic environment a drop in pH due to pro-
tonation of highly conserved histidine residues triggers major
rearrangement (homodimers dissociation to form intermediate
monomers) in the E protein, [18–20]. As a result, As a result, the C-
terminal fusion protein of E protein exposes and primes the E
protein for contact with the host endosomal membrane. During
this fusion process, a ﬂexible region between domain I and IIBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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close proximity (insertion) with the host membrane, [17,21]. Upon
the transformation of the E monomers into homotrimers the
fusion process ends, the anchor of the E protein then pulled back
with the fusion peptide-inserted endosome membrane to com-
plete the fusion, [22,23].
Experimental results have indicated that in the absence of the
detergent n-octyl-β-D-glucoside (β-OG) binding in E protein, a
shift in the kl β-hairpin (residues 268–280) occurs that opens the
hydrophobic interface allowing the shift of hinge region to pro-
mote fusion. kl β-hairpin plays an important and basic structural
role in formation of fusion component trimers by initiating the
conformational changes at low pH [15]. In the presence of a
detergent (any small molecule, while β-OG in this case), kl loop
forms a hydrogen bond and a salt bridge with its dimer partner
resulting in the closeness of the holes in hydrophobic channel at
the interface between domains I and II. In contrast, absence of a
detergent shifts the kl loop in such a way that the hydrophobic
interface (pocket) opens up. This shift allows domain II to hinge
away from its dimer partner projecting the fusion peptide at the
tip toward the membrane of the target cell. These conformational
changes in the presence and absence of a detergent suggest that
the small molecules that bind in the ligand-binding pocket in
opened kl hairpin conformation may inhibit the infection in low
pH by premature triggering and preventing fusion, [21,24,25].
Naturally plants derived compounds are an important source
for the discovery and the development of new antiviral drugs
Recently, efforts have been made to ﬁnd effective antiviral sub-
stance among the natural compounds because of their high
accessibility and expected low side effects [26,28,29]. Numerous
phytochemicals are reported as antiviral compounds against
dengue viruses including ﬂavonoids [30–33]. After literature
screening, among the reported ﬂavonoids baicalein, ﬁsetin,
hesperetin, naringenin/ naringin, quercetin and rutin were selec-
ted (Table 1) due to their potential activity against DENV at dif-
ferent stages of viral life cycle but none of them investigated as
inhibitory ligand for E protein of dengue.
Antiviral activities have also been described for these ﬂavo-
noids against many different viruses; [34–36]. Baicalein, quercetin
and rutin are ﬂavones. Antiviral activity of baicalein and quercetin
is determined previously against DENV, JEV (Japanese encephalitis
virus) and herpes simplex virus type 1 (HSV-1) and type 2 (HSV-
2); [35,37,38]. Quercetin also was studied for the infectivity and
replication of polio-virus type 1, para-inﬂuenza virus type 3 (Pf-3),
respiratory syncytial virus (RSV), porcine epidemic diarrhea virus
and some types of human adenoviruses, [35,36,39–42]. Rutin has
been reported as anti DENV recently, [27]. Fisetin, hesperetin and
naringin are ﬂavonones. In vitro antiviral activities of hesperetin
have been reported against some RNA viruses, [43–45]. Naringenin
and hesperetin showed inhibitory activity on NSV (non-speciﬁcTable 1
Flavonoids reported as anti DENV in literature with their half maximal inhibitory conce
Flavonoids Food sources
Group Compound
Flavones Rutin Apple and papaya
Quercetin Apple, lemon and papaya
Baicalein Plant Chinese skullcap, and Indian trumpet ﬂow
Flavonones Fisetin Apples, strawberries, and grapes.
Hesperetin Citrus fruits
Naringenin/ Naringin Grapefruit, oranges and tomato's peel
a Vero (African green monkey kidney) cell line.
b C6/36 mosquito cell line derived from Aedes albopictus.vaginitis) infection. Antiviral activity of Fisetin and Naringin were
reported against DENV as well, [27].
Therefore considering the previous studies about ﬂavonoids
and binding pocket of E protein, we are interested to ﬁnd potential
small molecules and lead compounds to interrupt the fusion
process at very early stage of interaction with receptor. The small
molecules were docked ﬁrst time in our study in the opened
ligand-binding pocket of E Protein of DENV2 through molecular
docking approach suggesting that the bioﬂavonoid compounds
inserted at this position have ability to interrupt further con-
formational changes and hence can inhibit the fusion transition.2. Materials and methods
2.1. Target selection (model preparation)
2.1.1. Preparation of envelope (E) protein structure
The three-dimensional structure of E Protein of DENV-2 in
complex with n-octyl-beta-D-glucoside (βOG) was retrieved from
the RSC Protein Data Bank [PDB:1OKE]. By removing all crystal
water molecules the E Protein structure was prepared for mole-
cular docking processes. Small molecules (BMA, NAG, FUL and
βOG) were removed. E Protein and only βOG were saved as two
separate pdb ﬁles for controlled docking.
2.1.2. Pocket identiﬁcation
A hydrophobic pocket occupied by a small detergent molecule
βOG near the hinge region of E protein led to an interest for
designing fusion inhibitors targeting this pocket of E protein
(Reference [15, Figs. 1–3]). This pocket is proposed to be “ﬁt-
induced”; suggesting that molecules binding in the pocket will
result in the steric hindrance to the hinge movement, hence
hampering fusion process.
2.2. Ligand selection and preparation
The chemical structure of small molecules (Fig. 1) were
retrieved from ZINC and PubChem databases, [46,47]. 3D Pdb
structures were obtained by Chimera software, [48]. The ligand
molecules were then subjected to energy minimization through
PRODRG (an online tool use Gromos 96 force ﬁeld for energy
minimization), [49] Gasteiger charges were added to small mole-
cules through Autodock Tools and Torsdof were set accordingly.
2.3. Molecular docking
AutoDock Vina, [50] was used to perform molecular docking
due to its accuracy and its two order faster magnitude speed than
AutoDock 4, [51]. AutoDock Tools was utilized to prepare the input
pdbqt ﬁle for E protein [PDB: 1OKE] and to set the size and thentration (IC50).
Inhibitory activity (dengue serotype/cell line) References
No activity (DENV-2/Veroa) [43]
IC50¼35.7 μg/mL (DENV-2/ C6/36b and Vero monolayer cells) [27]
er IC50¼6.46 μg/mL (DENV-2/ C6/36 and Vero) [37]
IC50¼43.12 mg/mL (DENV-2/Vero) [43]
No activity (DENV-2/ Vero cells) [27]
IC50¼52.64 mg/mL (DENV-2/Vero) [27,43]
Fig. 1. Chemical structure selected of small molecules.
Fig. 2. Small molecules binding pose obtained through Autodock vina (A) Baicalein binds with Thr-48, Ala-50 and Gln-200 (B) Binding of Quercetin with Ala-50, Gln-200 and
Thr-280 (C) Fisetin Bindings with Thr-48, Ala-50, Gln-200, and Gln-271 and Thr-280 (D) Naringenin bindings with Ala-50. (Visualized by PyMOL).
A. Mir et al. / Informatics in Medicine Unlocked 3 (2016) 1–6 3center of the grid box. Polar hydrogen atoms and Kollman charges
were added to the three dimensional structure of 1OKE. Because
the pocket of E protein is near the hinge region the center was setat 9.13781.40446.564 in the dimensions of x, y and z using
1.000 Å spacing.
Fig. 3. Surface representation of dengue virus E protein [PDB: 1OKE] with the best
pose of selected ligand Quercetin. The key residues (cyan sticks labeled black) in
hydrophobic pocket involve in binding.
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The validation of docking was carried out by redocking the E
protein active ligand (βOG) into its binding site. PyMol was used as
visualization tool, [52]. The Program of Energetic Analysis of
Receptor Ligand System (PEARLS), [53] was used to do post-
docking analysis.
2.5. Drug scan
Using online chemo informatics tools Molinspiration and
admetSAR, [54] the drug scan was done to check the rule of ﬁve
(drug likeness) whether the compound has fulﬁlled the conditions
as drug candidate.3. Results
3.1. Molecular docking
Docking of selected ligand molecules onto the binding site
(pocket) of the E protein was performed using AutoDock Vina. After
docking, for each ligand molecules the best pose based on its
conformation and docking energy are selected. Binding afﬁnityTable 2
Validation of “Lipinski's Rule of Five” and interaction of ﬂavonoids with the binding afﬁn
Flavonoids M. W [g/mol] Log P HB(D) HB(A
Group Compound
Flavones Baicalein 270.24 2.227 3 5
Quercetin 302.238 1.943 5 7
Flavonones Fisetin 286.239 1.974 4 6
Naringenin 272.256 2.117 3 5
Molecular weight, Log P¼Octanol-water partition coefﬁcient value, HB (D)¼Hydrogen b
distance in Å, BA¼Binding Afﬁnity.calculations for all small molecules were carried out using the
scoring function algorithm (inspired by X-Score) implemented in
Autodock vina, [55].
The compounds that have stronger bindings to the respective
binding site with the highest binding afﬁnities as well as the
hydrogen bond interactions are tabulated (Table 2). Two com-
pounds i.e. hesperetin and rutin deviated from binding pose
because of their structure and their inhibitory effect was also not
previously determined (Table 1). They also did not show good
bindings due to which these are not included.
Depending upon the number of hydrogen bonds formed
between the ligand and the protein the docking results were
evaluated. The molecular docking results of the small molecules
depending upon higher afﬁnity obtained for ﬂavones and ﬂava-
nones are shown (Fig. 2). The small molecules are shown in stick
model and the key molecules in each pose are labeled with bond
distance shown in dotted lines. Protein structure is shown in
surface model with the binding pocket residues are highlighted as
stick and labeled. The best pose ligand obtained in this analysis is
shown in the pocket surface (Fig. 3).
Within 4 Å of ligand, amino acid residues of complex (docked)-
protein were identiﬁed and visualized through PyMOL and infer-
red. There were some ﬁve prominent interactions observed
between the ﬁsetin and the binding site residues Thr-48, Ala-50,
Gln-200, Ile-270 and Thr-280 of receptor E protein. Two hydrogen
interactions between oxygen atoms of Ile-270 and Thr-280 with
different H-atoms of ﬁsetin were observed. The bond distance was
2.5 Å and 2.8 Å respectively. Nitrogen atoms of ALA-50 and Gln-
200 formed ionic interactions with oxygen of ligand having bond
distance of 3.0 Å. Baicalein through ionic interactions binds with
Thr-48, Ala-50 and Gln-200 and the bond distance was 2.9 Å and
3.1 Å. Common binding residues (Thr-48, Ala-50, Gln-200 and Thr-
280) in binding pocket of E protein were observed for baicalein,
ﬁsetin and quercetin. Quercetin binds in pocket by two ionic and
one hydrogen bond interaction. The two opposite oxygen atoms of
quercetin binds through bond distance of 3.1 Å and 3.0 Å with
nitrogen of Ala-50 and Gln-200 respectively. The only hydrogen
interaction formed in this complex was between hydrogen of
quercetin and oxygen of Thr-280 with the bond distance of 2.4 Å.
Naringenin binds through oxygen interacting with nitrogen of Ala-
50 forming an ionic interaction with bond distance of 2.9 Å.
Docking experiments showed that the small molecules also asso-
ciated with amino acid residues critical for membrane fusion, Thr-
48, Ala-50, Gln-200, ILeu-270 and Thr-280 in the hydrophobic β-
OG pocket of the E protein. The hydrogen, ionic interactions and
hydrophobic bindings of ligand-protein docked complex are
summarized (Table 2).ity calculated through Autodock vina visualized through PyMOL.
) HB (H-O) IB(N-O) BA(kcal/mol)
Residues BD(Å) Residues BD(Å)
Thr:48 3.2 Ala:50 2.9 8.5
Gln:200 3.1
Thr:280 2.4 Ala:50 3.13. 7.1
Gln:200 0
Thr:48 3.0 Ala:50 3.0 7.3
Ile:270 2.52.8 Gln:200 3.0
Thr:280
Ala:50 2.9 8.1
ond donor, HB (A)¼Hydrogen Bond Acceptor, HB¼Hydrogen Bond, BD (Å)¼Bond
Table 3
Vander waals, electrostatic and hydrogen bond energies of protein-ligand complex
calculated by PEARLS.
PEARL Parameters (Kcal/mol) Flavonoids
Flavones Flavonones
Baicalein Quercetin Fisetin Naringenin
Vander waals 8.01 8.35 8.53 7.37
Electrostatic 0.19 0.07 0.40 0.01
Hydrogen bond 1.24 1.66 1.59 0.61
Solvation free 0.29 1.61 1.33 0.34
Total Interaction energy 9.14 8.48 9.19 7.64
Conformational entropy 0.00 0.00 0.00 0.00
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Drug likeliness of the compounds and Molecular properties are
analyzed on the basis of “Lipinski's Rule of Five”, [56] using the
tool Molinspiration server (http://www.molinspiration.com). Phar-
macokinetics properties of drug including absorption, distribution,
metabolism and excretion in the human body are described by this
rule. These compounds are checked for the drug-likeliness and the
results of “Lipinski's Rule of Five” are shown (Table 2). Analysis
showed that all the small molecules passed through the ﬁlter
without any violations against the Lipinski's rule of ﬁve. We also
employed the use of admetSAR tool for in silico screening ADMET
proﬁles of the active compounds. The admetSAR server predicts
the ADMET-associated properties of the active compounds for
different types of models all of which showed positive results for
Quercetin only (data not included/shown).
3.3. Docking evaluation
To validate our grid parameters in Autodock Vina, the β-OG
molecule was re-docked in the pocket of 1OKE using same para-
meters after energy minimization. The compound β-OG docked in
the pocket with RMSD of 0.2 Å with 5.1 afﬁnity energy (Kcal/
mol). This binding validated our docking result as well. Post
docking energies for these active molecules were calculated
through PEARLS and are depicted in (Table 3).4. Discussion
Envelope protein of a virus plays a critical role in virus
attachment to a receptor and facilitates fusion process. At the stage
of viral entry, inhibition of fusion process provides a route for
therapeutic intervention. In the present study, the ﬂavonoid
quercetin possesses 5 hydrogen bond donors and 7 hydrogen bond
acceptors binds within the hydrophobic pocket of E protein with
the highest binding afﬁnity (8.48 Kcal/mol) compared to other
docked molecules. Quercetin binds within the pocket in an exact
manner as experimentally determined binding of detergent β-OG.
The head of ligand molecule lies at the mouth of pocket forming
hydrogen bonds at position 50, 200 and 280 and hydrocarbon
chain of quercetin projects well in the hydrophobic cavity.
Hydrogen bond formation at several positions results in ﬁxation of
an ordered orientation of kl hairpin suggesting the appropriate
binding as demonstrated by Modis et al., 2003 [15].
ADME proﬁling of active compounds proves that only the com-
pounds quercetin has no side effects upon its absorption. Fisetin and
baicalein also showed good bindings and did not violate “Lipinski's
Rule of ﬁve” but they do not showed good ADME proﬁling. The
major challenge in drug discovery process is the evaluation of
ADME properties of lead compounds.Our results evaluate and correlate with the experimental work
by Zandi et al., [27] in which they demonstrated quercetin is the
only compound that showed signiﬁcant antiviral activity against
DENV-2 in Vero cells. Taken together, our data strongly suggests
that Quercetin interacts with the E protein and therefore can
blocks the virus entry process by inhibiting the hinge regions
conformational changes, hence prevents fusion process. These
compounds do not even work as fusion inhibitors, but as inhibitors
of further steps in dengue virus replication. Furthermore, ADME
and toxicity risk assessment also strengthen our suggestion that
quercetin have marked antiviral activity against DENV2 virus. The
precise mode of action remains to be characterized.5. Conclusions
Flavonoids have received much attention in the literature over
the past 10 years. Besides nutritional value their potential bene-
ﬁcial effects have been elucidated. As the E protein plays a crucial
role in the fusion of the viral membrane with the target cell
membrane, for inhibition of infection of DENV it is necessary to
interrupt this early event. The ﬂavonoid quercetin found in Carica
papaya, apple and even in lemon might exert its antiviral activity
against fusion mechanism of DENV-2 by blocking the conforma-
tional rearrangement in envelope protein. The computational and
in vitro demonstrations that ﬂavonoids including quercetin pos-
sess anti DENV properties does not necessarily translate into
immediate use of these compounds as antiviral against DENV. To
demonstrate the antiviral activities of these compounds further
studies will be needed against different genotypes of dengue virus.
Furthermore appropriate animal model are required to check the
efﬁcacy of these compounds. Such information will eventually be
translated into new approaches to control dengue virus infection.Acknowledgements
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